What to watch for
Check the medicine, who reviewed your health, and how to get help. Before trusting a low price, check the prescription and the pharmacy’s license.
Medicine review in the U.S. is a role of the Food and Drug Administration, shortened here to FDA.
As of September 26, 2026, liraglutide had approved generics: copies of brand-name drugs for diabetes and for weight care.
The generics for weight care cannot be swapped for the diabetes generics at the pharmacy.
Ask which product is on the prescription.
Compounding is preparing a medicine to order; a pharmacist, doctor, or business registered for batch production with FDA can do this.
As of September 26, 2026, compounded drugs had no FDA review of their quality, safety, or effect before sale.
What is the reason for offering you a drug prepared to order? Ask the care service to explain.
Read the comparison: Ask which exact medicine the pharmacy will supply, then check whether the quote names that medicine.
Federal law on September 26, 2026 prohibited dispensing prescription drugs unless there was a valid prescription.
FDA’s online-pharmacy checklist calls for a pharmacist who can answer questions and a state pharmacy license.
Ask which pharmacy will supply the medicine. Check its record using the state license search.
As of September 26, 2026, FDA registration did not mean that a facility or its drugs had FDA approval.
FDA flags unusually low prices as one warning sign, but price alone does not prove an offer is false.
Look at the prescription, the pharmacy record, and the plan for later questions together.
Read the comparison: Use the state license search to check the pharmacy’s license. Ask who will answer questions about the medicine between visits.
As of September 26, 2026, liraglutide injection remained on FDA’s national shortage list.
That listing affects when pharmacies may make copies of a drug.
As of September 26, 2026, FDA had proposed leaving liraglutide off a list of raw ingredients that registered businesses may use to make batches of medicine.
FDA said it had not found a medical need for these businesses to make liraglutide from raw ingredients.
The proposal was not a final decision as of September 26, 2026.
For the exact drug being offered to you, have the prescriber explain which rule permits it to be made to order. Ask whether the shortage listing affects that answer.
In adult liraglutide (Saxenda) trials, nausea affected 39.3% of people on the drug and 13.8% on placebo.
Nausea means feeling sick to your stomach. A placebo is a dummy treatment with no active drug.
Ask what help is available if stomach trouble gets in the way of care.
The liraglutide labels carry a boxed warning, their most prominent kind, about thyroid tumors found in rats and mice.
Whether liraglutide causes those tumors in people remains unknown.
The labels rule out liraglutide when medullary thyroid cancer, a specific thyroid cancer, has affected the person or someone in their family.
The labels also rule it out for MEN 2, a rare condition that runs in families.
The labels also bar liraglutide after a serious allergic reaction caused by the drug itself or any ingredient in it.
Read the comparison: Ask the person providing your care how they will review your health history and help if you feel unwell.